Jubilant Biosys offers its customers end-to-end genome data analysis services to address one of the most obvious challenges faced by pharma industry today.
Our genome services ranges from sequence annotation to functional mapping and are characterized by our proficiency in cutting edge tools and our vast experience in processing R&D data. Jubilant’s genome analysis capabilities are well supported by its proprietary Discovery Informatics Gateway (DIG) platform which comprises pathway, biomarker and small molecule databases as they extensively cover various cancer types providing Jubilant an edge in annotations.
- Microarray analysis
- Next Generation Sequencing(NGS) - CHiP- Sequence, RNA-Sequence
- Functional Mapping: Genome to Pathway